Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Bruce Raben resigned as director at Hypha Labs, Inc..
- Action
- resigned
- Role
- director
Exact text from the filing
On May 2, 2023, Bruce Raben submitted a letter to the Company resigning from his position as a director of the Company.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.98
Hypha Labs, Inc. entered into Asset Purchase Agreement with DPL NV, LLC valued at cash purchase price of $2,300,000 (effective 2022-04-20).
- Action
- entry
- Agreement
- asset purchase
- Counterparty
- DPL NV, LLC
- Value
- cash purchase price of $2,300,000
- Effective
- 2022-04-20
Exact text from the filing
On April 20, 2022, Digipath, Inc. (“the “Company”), and Digipath Labs, Inc. (“Digipath Labs”), a wholly-owned subsidiary of the Company, entered into an Asset Purchase Agreement (the “Purchase Agreement”) with DPL NV, LLC (“Buyer”), pursuant to which Digipath Labs has agreed to sell substantially all of its assets to Buyer for a cash purchase price of $2,300,000
View on SEC.gov